Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Drug Innovation Will Accelerate Chinese Industry Shakeout

This article was originally published in PharmAsia News

Executive Summary

China's pharmaceutical manufacturing and innovation project, which seeks to boost the local industry's innovative capability, will support research and development and market expansion of key drugs. Within five years, the government hopes to see products with annual sales of 10 billion yuan as well as grow local enterprises that can compete with international pharmaceutical giants. Analysts believe that under the initiative, strong players with innovative strategies will thrive while weaker ones will be acquired by big enterprises or get eliminated. Generic drug and traditional Chinese medicine innovations are some possible approaches to creating new drugs without patent infringement, while talent, land, taxation laws, and supporting policies, such as a shorter drug approval process will help spur local innovation. (Click here for more)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts